These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27458160)

  • 1. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth.
    Wang S; Lu J; You Q; Huang H; Chen Y; Liu K
    Oncotarget; 2016 Aug; 7(33):53269-53276. PubMed ID: 27458160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium.
    Peng K; Fan X; Li Q; Wang Y; Chen X; Xiao P; Passerini AG; Simon SI; Sun C
    J Mol Cell Cardiol; 2020 Mar; 140():30-41. PubMed ID: 32087218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.
    Craps J; Joris V; De Jongh B; Sonveaux P; Horman S; Lengelé B; Bertrand L; Many MC; Colin IM; Gérard AC
    Endocrinology; 2016 Jun; 157(6):2545-59. PubMed ID: 27035650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
    Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
    Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
    Wang Y; Zhao Q; Ma S; Yang F; Gong Y; Ke C
    IUBMB Life; 2007 Nov; 59(11):717-21. PubMed ID: 17968710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF.
    Medici D; Olsen BR
    PLoS One; 2012; 7(8):e42913. PubMed ID: 22900063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.
    Huber S; Bruns CJ; Schmid G; Hermann PC; Conrad C; Niess H; Huss R; Graeb C; Jauch KW; Heeschen C; Guba M
    Kidney Int; 2007 Apr; 71(8):771-7. PubMed ID: 17299523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway.
    Park JW; Kim WH; Shin SH; Kim JY; Yun MR; Park KJ; Park HY
    Biochim Biophys Acta; 2011 May; 1813(5):763-71. PubMed ID: 21329734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.
    Koldehoff M; Beelen DW; Elmaagacli AH
    Cancer Gene Ther; 2014 Jul; 21(7):275-82. PubMed ID: 24903015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study.
    Korybalska K; Kawka E; Breborowicz A; Witowski J
    J Physiol Pharmacol; 2017 Jun; 68(3):397-405. PubMed ID: 28820396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits the proliferation of endothelial cells in hemangioma by blocking the mTOR-FABP4 pathway.
    Wang Y; Chen J; Tang W; Zhang Y; Li X
    Biomed Pharmacother; 2017 Jan; 85():272-279. PubMed ID: 27914823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.
    Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS
    J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression.
    Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
    In Vitro Cell Dev Biol Anim; 2016 Jan; 52(1):45-8. PubMed ID: 26427711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular repressor of E1A-stimulated genes regulates vascular endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling pathway.
    Zhang H; Han Y; Tao J; Liu S; Yan C; Li S
    Exp Cell Res; 2011 Dec; 317(20):2904-13. PubMed ID: 21939655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells.
    Zhan JK; Wang YJ; Wang Y; Wang S; Tan P; Huang W; Liu YS
    Can J Cardiol; 2014 May; 30(5):568-75. PubMed ID: 24518659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation.
    Jia J; Ye T; Cui P; Hua Q; Zeng H; Zhao D
    Microvasc Res; 2016 May; 105():103-8. PubMed ID: 26860974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.